반응식
[CH3:1][C:2]1([CH3:26])[CH2:11][CH2:10][C:9]([CH3:13])([CH3:12])[C:8]2[CH:7]=[C:6]([C:14]([O:16][C:17]3[CH:25]=[CH:24][C:20]([C:21](N)=[O:22])=[CH:19][CH:18]=3)=[O:15])[CH:5]=[CH:4][C:3]1=2.[OH:27][C:28]1C=CC(C(N)=O)=C[CH:29]=1>>[CH3:1][C:2]1([CH3:26])[CH2:11][CH2:10][C:9]([CH3:13])([CH3:12])[C:8]2[CH:7]=[C:6]([C:14]([O:16][C:17]3[CH:25]=[CH:24][C:20]([C:21]([O:27][CH2:28][CH3:29])=[O:22])=[CH:19][CH:18]=3)=[O:15])[CH:5]=[CH:4][C:3]1=2참가 물질
3
실험 절차
4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthoyloxy)benzamide-Using 4-hydroxybenzamide, the title compound was synthesized as a white solid. PMR (CDCl3): δ 1.35 (6H, s), 1.37 (6H, s), 1.76 (4H, s), 7.32 (2H, d, J~8.6 Hz), 7.48 (1H, d, J~8.4 Hz), 7.89-7.98 (3H, m), 8.17 (1H, d, J~1.9 Hz).
출처 및 근거
- ORD 기록
- ord-8698c61e71b84a9da03c69b9d478a7ca
- 출처 데이터셋
- uspto-grants-1993_07
- 특허 번호
- US05231113
연결된 노트
불러오는 중…